Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi
Background and Objectives : Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardiovascular disease and protect the remaining...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Qom University of Medical Sciences
2014-04-01
|
| Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
| Subjects: | |
| Online Access: | http://journal.muq.ac.ir/article-1-166-en.html |
| _version_ | 1818669088785825792 |
|---|---|
| author | Vajihe Biniaz Mahdi Sadeghi Shermeh Ali Tayebi Abbas Ebadi Eghlim Nemati |
| author_facet | Vajihe Biniaz Mahdi Sadeghi Shermeh Ali Tayebi Abbas Ebadi Eghlim Nemati |
| author_sort | Vajihe Biniaz |
| collection | DOAJ |
| description | Background and Objectives : Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardiovascular disease and protect the remaining function of kidneys in patients withchronic renal failure. This study was performed with the objective of evaluating the frequency of dyslipidemia and its accompanying factors in hemodialysis patients. Methods: In a descriptive cross-sectional study, 182 patients with chronic renal failure referred to hemodialysis units of Baqiyatallah and Shahid Chamran hospitals, Tehran in 2012 were studied. Fordata collection, in addition to demographic questionnaire, serum levels of cholesterol, triglyceride, HDL and LDL were measured. Data analysis was done using Chi-square, independent t-test, and one-way ANOVA. The significance level was considered to be p<0.05. Results: In this research, 8.2% of the patients had hypercholesterolemia, 26.4% hypertriglyceridemia, and 6.8% LDL level more than 130. In half of the patients, serum HDL was less than 35. A significant relationship was observed betweendyslipidemiaand variables of gender (p=0.001), duration of hemodialysis (p=0.004), education level (p=0.005), and weight (p=0.007). Conclusion: Dyslipidemiahas a high prevalence in hemodialysis patients, especiallypatients with low literacy and obesity. So that, at least one of the components of lipid profilesis abnormalin more than 80% of hemodialysis patients. Therefore, planning to improve life style and provide training on proper nutrition and physical activity is recommended as one of the principles of care in hemodialysis patients. |
| first_indexed | 2024-12-17T06:46:39Z |
| format | Article |
| id | doaj.art-0bc21617c0de4882b183fefec2345c1b |
| institution | Directory Open Access Journal |
| issn | 1735-7799 2008-1375 |
| language | fas |
| last_indexed | 2024-12-17T06:46:39Z |
| publishDate | 2014-04-01 |
| publisher | Qom University of Medical Sciences |
| record_format | Article |
| series | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
| spelling | doaj.art-0bc21617c0de4882b183fefec2345c1b2022-12-21T21:59:44ZfasQom University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum1735-77992008-13752014-04-01811015Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardiVajihe Biniaz0Mahdi Sadeghi Shermeh1Ali Tayebi2Abbas Ebadi3Eghlim Nemati4 Baqiyatallah University of Medical Sciences Baqiyatallah University of Medical Sciences Baqiyatallah University of Medical Sciences Baqiyatallah University of Medical Sciences Baqiyatallah University of Medical Sciences Background and Objectives : Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardiovascular disease and protect the remaining function of kidneys in patients withchronic renal failure. This study was performed with the objective of evaluating the frequency of dyslipidemia and its accompanying factors in hemodialysis patients. Methods: In a descriptive cross-sectional study, 182 patients with chronic renal failure referred to hemodialysis units of Baqiyatallah and Shahid Chamran hospitals, Tehran in 2012 were studied. Fordata collection, in addition to demographic questionnaire, serum levels of cholesterol, triglyceride, HDL and LDL were measured. Data analysis was done using Chi-square, independent t-test, and one-way ANOVA. The significance level was considered to be p<0.05. Results: In this research, 8.2% of the patients had hypercholesterolemia, 26.4% hypertriglyceridemia, and 6.8% LDL level more than 130. In half of the patients, serum HDL was less than 35. A significant relationship was observed betweendyslipidemiaand variables of gender (p=0.001), duration of hemodialysis (p=0.004), education level (p=0.005), and weight (p=0.007). Conclusion: Dyslipidemiahas a high prevalence in hemodialysis patients, especiallypatients with low literacy and obesity. So that, at least one of the components of lipid profilesis abnormalin more than 80% of hemodialysis patients. Therefore, planning to improve life style and provide training on proper nutrition and physical activity is recommended as one of the principles of care in hemodialysis patients.http://journal.muq.ac.ir/article-1-166-en.htmlrenal insufficiencykidney failurechronicrenal dialysisdislipidlipid peroxidation. |
| spellingShingle | Vajihe Biniaz Mahdi Sadeghi Shermeh Ali Tayebi Abbas Ebadi Eghlim Nemati Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum renal insufficiency kidney failure chronic renal dialysis dislipid lipid peroxidation. |
| title | Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| title_full | Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| title_fullStr | Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| title_full_unstemmed | Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| title_short | Background and Objectives: Dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients.Timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| title_sort | background and objectives dyslipidemia is a common disorder and one of the major causes of the atherosclerosis development and progression in hemodialysis patients timely diagnosis and treatment of dyslipidemia can reduce mortality and morbidity of cardi |
| topic | renal insufficiency kidney failure chronic renal dialysis dislipid lipid peroxidation. |
| url | http://journal.muq.ac.ir/article-1-166-en.html |
| work_keys_str_mv | AT vajihebiniaz backgroundandobjectivesdyslipidemiaisacommondisorderandoneofthemajorcausesoftheatherosclerosisdevelopmentandprogressioninhemodialysispatientstimelydiagnosisandtreatmentofdyslipidemiacanreducemortalityandmorbidityofcardi AT mahdisadeghishermeh backgroundandobjectivesdyslipidemiaisacommondisorderandoneofthemajorcausesoftheatherosclerosisdevelopmentandprogressioninhemodialysispatientstimelydiagnosisandtreatmentofdyslipidemiacanreducemortalityandmorbidityofcardi AT alitayebi backgroundandobjectivesdyslipidemiaisacommondisorderandoneofthemajorcausesoftheatherosclerosisdevelopmentandprogressioninhemodialysispatientstimelydiagnosisandtreatmentofdyslipidemiacanreducemortalityandmorbidityofcardi AT abbasebadi backgroundandobjectivesdyslipidemiaisacommondisorderandoneofthemajorcausesoftheatherosclerosisdevelopmentandprogressioninhemodialysispatientstimelydiagnosisandtreatmentofdyslipidemiacanreducemortalityandmorbidityofcardi AT eghlimnemati backgroundandobjectivesdyslipidemiaisacommondisorderandoneofthemajorcausesoftheatherosclerosisdevelopmentandprogressioninhemodialysispatientstimelydiagnosisandtreatmentofdyslipidemiacanreducemortalityandmorbidityofcardi |